News

Explore Latest News .

Find all the latest news on Paul Peter Tak, as well as a comprehensive list of his past interviews and features. Paul Peter’s work in immunology and the pharmaceutical industry has led him to be featured in both business and medicine specific publications.

During his time at GlaxoSmithKline, Paul Peter gave a number of interviews and briefs, including one with the Biochemical Society in 2017. In this insightful interview, Paul Peter outlined what the GSK Immunology Network was and its impact on this important area of research.

In December 2020, Paul Peter Tak spoke with Eleanor Malone, from Scrip, about the work Candel Therapeutics was undertaking in the field of cancer immunotherapy and the companies ambitious future. Paul Peter has also had more broad discussions around his career and what inspires him, such as his interview with Stephanie Sutton for The Medicine Maker, in 2020.   

Dr. Paul Peter Tak was included in ‘the Medicine Maker Power List 2023’

The Medicine Maker Power List 2023 Celebrating 30 influential and inspirational leaders across small molecule, biopharmaceutical, and cell and gene therapy development and manufacture The Medi…

Podcast: Developing Novel viral Immunotherapies to Improve Cancer Outcomes

https://www.youtube.com/watch?v=yhpyV9zARws Join us in this eye-opening YouTube video as we introduce Dr. Paul Peter Tak, a trailblazer in the field of biotechnology and the President, Chief Exec…

How we stumbled on the role of the vagus nerve in chronic inflammation

Link to the podcast Metagenics Institute Podcast: The Power and the Potential of the Vagus Nerve to Combat Inflammation with Prof Paul Peter Tak (fireside.fm) Introduction Welcome to “The P…

CEO Paul Peter Tak Transforms Candel and Cancer Treatment

About Paul Peter Tak The CEO of viral immunotherapy company Candel Therapeutics, Paul Peter Tak, MD, PhD, enjoys exploring the world with his family, experiencing different culture…

Candel Therapeutics’ enLIGHTEN Discovery Platform has been launched with the announcement of a partnership with the University of Pennsylvania

Candel Therapeutics’ New Partnership Candel Therapeutics is joining forces with Carl June’s lab at the University of Pennsylvania to see if the herpes virus can boost the effectiveness of CAR-T t…

Empowered Patient Podcast: Using oncolytic viral immunotherapy to kill solid tumors with Dr. Paul Peter Tak

Paul Peter Tak – Top podcast episodes (listennotes.com)
Paul Peter Tak

© Paul Peter Tak.
All rights reserved.